EvidenceUpdates: A randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain.

Note: meds in diabetic neuropathic pain are also used in cancer related neuropathic pain (consult oncologist)